Search results
Bride with terminal stage 4 cancer walks down the aisle in "dream" wedding
Newsweek· 9 hours agoMost couples vow to love each other through sickness and in health, but this bride and groom gave...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 8 hours agoASP-1929 received a fast track designation from the US Food and Drug...patients received both...
Guardant colon cancer test struggles to detect non-cancerous tumors, FDA says
MedTech Dive via Yahoo Finance· 6 days agoEarlier treatment could potentially cure the patient or prolong survival, FDA scientists said in...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 14 hours agoThe...objectives as the reason for the trial termination. The drug’s PTSR fell by 20 points in...
Panel recommends blood test to detect colon cancer for FDA approval
UPI· 5 days agocancers, and over a third of those cases are expected to be fatal. May 23 (UPI) -- A panel of U.S....
Support Early Detection Technology to Save the Lives of Black Cancer Patients - Los Angeles Sentinel
Los Angeles Sentinel· 6 days agoThe stark reality that Black women are 41% more likely to die from breast cancer than White women is a grim reminder of the systemic inequities that pervade our health care ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 6 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 4 days agoOncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024 American Society of Clinical ...
Mercy Bioanalytics Pushing Forward with Plans to Market Ovarian Cancer Blood Test
GenomeWeb News· 7 hours agoExtracellular vesicle diagnostics firm Mercy Bioanalytics is making progress in its plans to market and eventually garner US Food and Drug Administration approval for a novel ovarian